title: The authors reply.
authors.forename: Shokei
authors.initials: S
authors.lastname: Kim-Mitsuyama
authors.forename: Hisao
authors.initials: H
authors.lastname: Ogawa
authors.forename: Kunihiko
authors.initials: K
authors.lastname: Matsui
authors.forename: Tomio
authors.initials: T
authors.lastname: Jinnouchi
authors.forename: Hideaki
authors.initials: H
authors.lastname: Jinnouchi
authors.forename: Kikuo
authors.initials: K
authors.lastname: Arakawa
mesh_terms: D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000453:epidemiology*; D008297:Male; D051436:Renal Insufficiency, Chronic / Q000150:complications* / Q000453:epidemiology*
chemical_list: D057911:Angiotensin Receptor Antagonists; D002121:Calcium Channel Blockers